Normal cells possess adaptive mechanisms to couple energy availability with cell growth (cell size increase) and survival, and imbalances are associated with major diseases such as cancer. Inactivation of critical regulators involved in energy stress response, including adenosine monophosphate-activated protein kinase (AMPK), liver kinase B1 (LKB1), tuberous sclerosis complex 1 (TSC1) and tuberous sclerosis complex 2 (TSC2), leads to uncontrolled cell growth yet increased apoptosis under energy stress. These energy stress regulators are also important in tumor suppression and metabolism. Here, we show that forkhead box O (FoxO) transcription factor, a central regulator of tumor suppression and metabolism, plays a unique role in energy stress response. FoxOs inhibit the mammalian target of rapamycin complex 1 (mTORC1), a key regulator of cell growth, under energy stress, and inactivation of FoxOs alleviates energy stress-mediated mTORC1 repression. Surprisingly, unlike AMPK-, Lkb1-or Tsc1/2-deficient cells, FoxO-deficient cells exhibit decreased apoptosis under energy stress. FoxOs operate to inhibit mTORC1 signaling and cell survival independent of AMPK and TSC. Integrated transcriptomic and functional analyses identified BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3)-a negative regulator of both Rheb and Bcl2 prosurvival family members-as a key downstream target of FoxOs to inhibit mTORC1 function and promote apoptosis in response to energy stress. We show that p38b, but not AMPK, is likely to function upstream of FoxO-BNIP3 to mediate energy stress response. Finally, we reveal that low expression of FoxO or BNIP3 correlates with poor clinical outcomes in renal cancer patients. Together, our study uncovers a novel signaling circuit functioning to mediate cellular energy responses to control cell growth and survival. These findings also have important implications to human cancers.
INTRODUCTION
Normal cells possess metabolic checkpoints to sense energy availability and control cell growth (cell size increase) and survival in response to energy stress. One critical sensor of cellular energy status in all eukaryotic cells is the adenosine monophosphateactivated protein kinase (AMPK). 1, 2 Energy stress increases cellular adenosine monophosphate/adenosine triphosphate ratio and activates AMPK. The activation of AMPK also requires AMPK phosphorylation by the upstream kinase liver kinase B1 (LKB1). Once activated, AMPK phosphorylates various downstream targets to activate adenosine triphosphate-generating catabolic processes and inactivate adenosine triphosphate-consuming anabolic processes, thus restoring energy balance and maintaining cell survival under conditions of energy stress. 3 One major anabolic process inhibited by AMPK in response to energy stress is protein synthesis and cell growth. 1, 2 The mammalian target of rapamycin complex 1 (mTORC1) functions as the master regulator to promote protein synthesis and cell growth. [4] [5] [6] [7] mTORC1 consists of mTOR, Raptor and other protein components, among which mTOR functions as a Ser/Thr kinase to phosphorylate downstream targets involved in protein synthesis and growth control, including S6 kinase (S6K) and 4EBP1, whereas Raptor functions as a scaffold protein regulating the assembly, localization and substrate binding of mTORC1. 4 A critical upstream regulator of mTORC1 is the TSC1-TSC2 complex, in which TSC1 serves to maintain the protein folding and stability of TSC2, whereas TSC2 functions as the GTPase-activating protein of the small GTPase Rheb. In its guanosine triphosphate-bound active form, Rheb can potently activate mTORC1. By stimulating Rheb guanosine triphosphate hydrolysis, the TSC1-TSC2 complex inactivates mTORC1 and restrains cell growth. 8, 9 The inhibition of mTORC1 and cell growth by energy stress involves AMPK phosphorylation of TSC2 and Raptor. AMPKmediated phosphorylation of TSC2 promotes the inhibitory function of the TSC1-TSC2 complex on mTORC1 activation, whereas AMPKmediated Raptor phosphorylation suppresses mTORC1 activation by Raptor. 10, 11 This signaling axis serves to restrain cell growth and promote cell survival during energy stress. Accordingly, inactivation of LKB1, AMPK, TSC1 or TSC2, or reconstitution of cells with a Raptor mutant that is non-phosphorylatable by AMPK, rendered cells more resistant to energy stress-mediated mTORC1 inactivation but more sensitive to energy stress-induced apoptosis. [10] [11] [12] [13] [14] [15] As with other stress response, long-term energy stress will eventually induce apoptosis; however, much less is known about the coordination between apoptosis-promoting mechanism and mTORC1 inhibition in response to energy stress.
Although most current studies focus on AMPK-dependent mechanisms in the regulation of energy stress response, very recent studies also suggest AMPK-independent energy stress pathways. For example, it has been shown that p38b inactivates Rheb and thus inhibits mTORC1 under energy stress conditions via AMPK-TSC-independent mechanisms. 16 Other recent studies revealed that the TTT-RUVBL1/2 complex and Rag GTPases are involved in energy depletion regulation of mTORC1 signaling most likely through AMPK-TSC-independent mechanisms. 17, 18 In contrast to our deep understanding of AMPK-mediated energy stress signaling, the roles and mechanisms of AMPK-independent pathways in energy stress response still remain largely unknown.
The mammalian forkhead box O (FoxO) transcription factors, particularly FoxO1, FoxO3 and FoxO4, function to direct the transcription of specific gene targets in the nucleus and mainly function to promote cell cycle arrest and apoptosis and regulate metabolism and stress response. 19, 20 FoxOs can be regulated by different upstream signaling pathways, including the phosphatidylinositol 3-kinase-AKT pathway, and various stress signaling pathways via post-translational modifications, including phosphorylation. 21 Activation of phosphatidylinositol 3-kinase by extracellular growth factors leads to AKT-mediated phosphorylation of FoxO transcription factors, resulting in their sequestration in the cytoplasm such that FoxOs are unable to regulate their gene targets. On the other hand, FoxO phosphorylation by other kinases involved in stress response, such as c-Jun N-terminal kinase, generally promotes FoxO nuclear localization and/or activates the transcriptional activities of FoxOs. 21 FoxOs play very context-specific functions such that they regulate the expression of very different gene targets under different conditions. LKB1, TSC1, TSC2 and FoxOs play important roles in the phosphatidylinositol 3-kinase-AKT signaling network and function as tumor suppressors and are mutated or deleted in various human cancer syndromes and sporadic cancers. 22 In line with this, mouse genetic studies have established that deletion of these tumor suppressors resulted in tumor development in vivo. [23] [24] [25] [26] [27] [28] In this study, we show that, different from LKB1 and TSC, FoxOs play a unique role of inhibiting both mTORC1 signaling and cell survival in response to energy stress and operate in an AMPKindependent mechanism. Our study thus reveals a previously unappreciated mechanism to mediate cellular energy responses to control cell growth and survival. Our data further suggest that dysregulation of this signaling axis is associated with human cancers, including renal cancer.
RESULTS
FoxOs suppress mTORC1 activation in response to energy stress To study the potential roles of FoxOs in the regulation of mTORC1 signaling, we generated matched FoxO WT and KO primary mouse embryonic fibroblasts (MEFs) via transient treatment of FoxO1/3/4L/L, Rosa26-CreERT2 MEFs with either vehicle or 4-hydroxytamoxifen (4OHT) (Figure 1a and Supplementary Figure 1 ) and then examined mTORC1 activity in response to various stimuli in these cells. The analyses revealed that although serum or amino-acid starvation led to dephosphorylation of S6K and S6, the biochemical surrogates of mTORC1 activation, to similar levels in both FoxO WT and KO MEFs (Supplementary Figure 2) , S6 and S6K dephosphorylation induced by glucose deprivation, which elicits energy stress, was significantly compromised in FoxO KO MEFs compared with that in matched WT MEFs (Figure 1b ). S6 and S6K phosphorylation was abolished by rapamycin treatment in FoxO KO MEFs under glucose starvation (Supplementary Figure 3) , suggesting that FoxO regulation of S6K and S6 phosphorylation is mediated by mTORC1. We observed similar effects upon treatment of other energy stress inducers, including adenosine monophosphate mimetic 5-aminoimidazole-4-carboxamide riboside (AICAR) (Figure 1c ) and the glucose analog 2-deoxy-glucose (data not shown). Correspondingly, glucose starvation led to cell size reduction in MEFs, but this reduction was less in FoxO KO MEFs than in WT MEFs (Figure 1d ).
In line with these data from the murine system, further experiments in human renal cell carcinoma (RCC) cells (Figures 1e and f) confirmed that knockdown of FoxOs similarly alleviated energy stress-induced mTORC1 repression. It should be noted that knockdown of FoxO1 or FoxO3 was sufficient to alleviate mTORC1 inactivation under energy stress, but knockdown of both FoxO1 and FoxO3 had a more potent effect (Figure 1f) . Together, these data reveal that FoxOs selectively regulate energy stress-induced mTORC1 inactivation, and deletion of FoxOs leads to mTORC1 hyperactivation under energy stress. FoxOs potentiate energy stress-induced apoptosis It is well established that the LKB1-AMPK-TSC signaling axis functions to suppress mTORC1 activation and promotes cell survival under conditions of energy stress.
10,12-14 The data described above thus prompted us to examine the impact of FoxO deficiency on energy stress-induced apoptosis. Surprisingly, although FoxO KO MEFs behaved similarly to AMPK, Lkb1, Tsc1/2 KO MEFs in the regulation of energy stress-mediated mTORC1 inactivation (Figure 1 ), the cells functioned oppositely in the regulation of cell survival: FoxO KO MEFs exhibited dramatically reduced apoptosis compared with FoxO WT MEFs under glucose starvation, as evidenced by both cleaved caspase-3/poly (ADP-ribose) polymerase western blotting (Figure 2a ) and the Annexin V staining (Figures 2b and c) . Treatment with other energy stress inducers, such as AICAR, had similar effect in FoxO KO MEFs (Figure 2d ). Although rapamycin treatment significantly rescued the enhanced apoptosis in Tsc1 KO and Lkb1 KO MEFs under glucose starvation (data not shown), rapamycin treatment did not affect apoptosis in FoxO KO MEFs under glucose starvation (Supplementary Figure 4) , suggesting that FoxO regulation of energy stress-induced apoptosis is mTORC1 independent. Taken together, these data strongly suggest that FoxOs and TSC/LKB1 exert differential functions in the regulation of energy stressinduced apoptosis.
The above data from MEFs prompted further examination of FoxO function in energy stress-induced apoptosis in human cancer cells. We examined the expression levels of FoxO1/3 and mTORC1 activation status in a panel of human RCC cell lines and identified five RCC cell lines with similarly high level of S6 phosphorylation (786-O, UMRC2, UOK101, A498 and RCC4) (Figure 2e ). We then examined whether there is any correlation between cell survival response to glucose deprivation and the FoxO1/3 expression levels in these cells. We found that the RCC cells with high expression of FoxO1 and/or FoxO3 (786-O, UOK101 and A498) were more prone to glucose deprivation-induced apoptosis than RCC cells with low expression of both FoxO1 and (Figures 1e and f) . Collectively, these data from human cancer cells are in line with the MEF studies demonstrating that FoxOs promote energy stress-induced apoptosis.
FoxOs operate in parallel to TSC to mediate energy stress response The above observations prompted more in-depth analysis of FoxO regulation of other known players involved in energy stress in the regulation of energy stress response A Lin et al response. As AMPK acts as a critical sensor of cellular energy status, 1,2 we first examined AMPK activation status in FoxO WT and KO MEFs under energy stress conditions. We found that FoxO deletion did not affect glucose starvation or AICAR-induced AMPK phosphorylation at Thr172, which is required for AMPK catalytic activity, or AMPK phosphorylation of key downstream targets, such as acetyl-CoA carboxylase, TSC2 or Raptor (Figures 3a and b) . The same observation was also made in 786-O cells with FoxO1 and FoxO3 double knockdown (Supplementary Figure 7) . Thus, it appears that FoxOs are not involved in energy stress-induced AMPK activation or AMPK phosphorylation of its downstream targets.
We further studied the genetic interaction between TSC and FoxOs in the regulation of energy stress response. Consistent with previous reports, 11, 29 we observed that although Tsc1 deletion rendered cells more resistant to AICAR treatment-induced mTORC1 inactivation, AICAR treatment still inhibited mTORC1 activity in Tsc1 KO MEFs (Figure 3c ). Notably, compared with Tsc1 KO MEFs, Tsc1/FoxO compound KO MEFs were more resistant to AICAR-induced mTORC1 inactivation (Figure 3c ). In addition, although Tsc1 KO MEFs were more sensitive, and FoxO KO MEFs were more resistant, to glucose starvation-induced apoptosis, Tsc1/FoxO KO MEFs showed intermediate apoptosis rate under glucose starvation (Figure 3d ). Together, our data reveal that FoxOs operate in parallel to the TSC1-TSC2 complex to regulate mTORC1 and cell survival under energy stress.
FoxOs regulate energy stress-induced BNIP3 expression
We next sought to determine the underlying mechanisms by which FoxOs regulate mTORC1 signaling and cell survival in response to energy stress. To this end, we conducted comparative transcriptome analysis in three pairs of matched FoxO WT and KO primary MEFs after culturing in a glucose-containing or glucosefree medium (Figure 4a ). The computational analysis identified 82 genes that are differentially regulated by glucose deprivation, and of which the expression levels under glucose starvation are at least partially regulated by FoxOs, including 72 downregulated genes (genes are upregulated upon glucose starvation, and their expression levels are downregulated in FoxO KO MEFs compared with in WT MEFs under glucose starvation) and 10 upregulated genes (genes are downregulated upon glucose starvation, and Table 1) . Interestingly, all of the top-list genes are from the downregulated gene group, suggesting that FoxOs mainly function as a transcription activator in energy stress response.
Although FoxO regulation of energy stress response may involve different downstream targets, we focused on the roles of BNIP3 in mediating FoxO functions in mTORC1 signaling and cell survival in response to energy stress, as BNIP3 is one of the most significantly regulated genes by FoxO under glucose starvation ( Figure 4b ) and BNIP3 has been shown to promote apoptosis by interaction with Bcl2 prosurvival family members [30] [31] [32] and to inhibit mTORC1 via interaction with Rheb. 33 It is well documented that cellular stress, such as hypoxia, leads to increased BNIP3 expression; 31 however, the roles and mechanisms of BNIP3 in energy stress response remain largely unknown. Realtime PCR and western blotting analysis in MEFs (Figure 4c ) confirmed that glucose starvation significantly induced BNIP3 expression and that FoxO deficiency abolished glucose starvation-induced BNIP3 expression. We further showed that AICAR treatment had similar effects on BNIP3 expression in FoxO WT and KO MEFs (Figure 4d ), suggesting that the regulation is not specific to glucose deprivation but general to energy stress induction. In addition, knockdown of FoxO1 and FoxO3 significantly attenuated the upregulation of BNIP3 expression induced by energy stress in UOK101 and 786-O cells (Figures 4e and f) .
A previous study identified BNIP3 as a direct target of FoxO3 in other cellular contexts. 34 However, under which physiological conditions FoxO regulates BNIP3 transcription remains less understood. Chromatin immunoprecipitation (ChIP) analysis documented that endogenous FoxO1 and FoxO3 can directly bind to the FoxO-binding element (BE) identified in BNIP3 promoter region, and energy stress significantly increased FoxO1/3 binding to FoxO BE in BNIP3 promoter (Figures 4g and  i) . We also generated luciferase reporter constructs containing BNIP3 promoter region with or without FoxO BE mutation. Luciferase reporter promoter assay showed that FoxO BE mutation significantly attenuated FoxO1-or FoxO3-induced BNIP3 promoter luciferase activity (Figure 4h) . Together, our data show that FoxOs directly upregulate BNIP3 transcription in response to energy stress. FoxO-BNIP3 in the regulation of energy stress response A Lin et al BNIP3 is a key downstream mediator of FoxO in energy stress response The data presented above prompted us to further study the relationship of FoxOs, BNIP3 and mTORC1 signaling. The time course experiment in MEFs revealed that the kinetics of AICARinduced BNIP3 upregulation correlated well with downregulation of S6 phosphorylation, both of which were significantly compromised in FoxO KO MEFs (Figure 5a ). Mirroring these findings from in vitro studies, we found that fasting led to marked induction of BNIP3 protein level and downregulation of mTORC1 activation in various organs from WT mice, and fasting-induced BNIP3 expression and mTORC1 inactivation were significantly attenuated in FoxO KO mice (Figure 5b ). These data strongly suggest that FoxOs regulate BNIP3 expression and mTORC1 inactivation under fasting condition in vivo. Next, we studied whether BNIP3 plays any causal role in FoxO regulation of mTORC1 signaling in response to energy stress. We showed that re-expression of BNIP3 in FoxO-deficient cells suppressed S6 and S6K phosphorylation to WT level under energy stress (Figure 5c ). Conversely, knockdown of BNIP3 alleviated energy stress-induced suppression of S6 and S6K phosphorylation in both 786-O cells and MEFs (Figures 5d and e) , a phenotype consistent with that observed in FoxO-deficient cells (also see Figure 1 ). It has been shown that BNIP3 mediates hypoxia-induced mTORC1 inactivation through interacting with Rheb, an upstream activator of mTORC1. 33 We found that glucose starvation significantly increased endogenous interaction between BNIP3 and Rheb, likely because more BNIP3 proteins are available to interact with Rheb under glucose deprivation condition, and the enhanced BNIP3-Rheb interaction was significantly attenuated in FoxO-deficient cells (Figure 5f ). Thus, our data strongly suggest that BNIP3 mediates energy stress-induced mTORC1 inactivation likely through its interaction with Rheb. Our data also align well with our earlier observation that FoxOs operate in parallel to TSC to regulate mTORC1 (also see Figure 3c ), as Rheb acts downstream of TSC to regulate mTORC1.
BNIP3 is a Bcl2 homology 3 domain-containing protein and functions to promote cell death likely via its interaction with other Bcl2 family prosurvival proteins. 31 However, the role of BNIP3 in energy stress-induced cell death remains unknown. Figure 6a shows that restoration of BNIP3 expression in FoxO KO MEFs induced potent cell death under glucose starvation. Conversely, knockdown of BNIP3 significantly attenuated apoptosis induced by glucose starvation (Figure 6b ) or AICAR treatment (Figure 6c ). Although rapamycin treatment fully suppressed S6 phosphorylation in BNIP3-knockdown cells under energy stress conditions (Figure 5e ), rapamycin treatment did not affect the apoptosis rate under the same condition (Figure 6b ). In addition, rapamycin treatment did not affect BNIP3 expression in FoxO KO MEFs under glucose starvation (Supplementary Figure 8) . Thus, same as FoxOs, BNIP3 regulates energy stress-induced apoptosis in an mTORC1-independent manner. Both FoxOs and BNIP3 have been shown to regulate autophagy. 30, 34 However, FoxO deletion or BNIP3 knockdown did not affect LC3-II level, a marker for active autophagy, under energy stress (Supplementary Figure 9) , suggesting that FoxOs and BNIP3 are not involved in energy FoxO-BNIP3 in the regulation of energy stress response A Lin et al stress-induced autophagy in the cell line we tested. Collectively, our data strongly suggest that BNIP3 is at least one key downstream target of FoxOs to inhibit mTORC1 signaling and promote apoptosis in response to energy stress.
p38b, but not LKB1-AMPK, is likely to function upstream of FoxOs to mediate energy stress response The data presented above prompted us to further study how the FoxO-BNIP3 signaling axis is regulated by energy stress to control mTORC1 and cell survival. The most obvious upstream regulator is AMPK. Indeed, it has been shown that AMPK can phosphorylate FoxO3. 35 However, we found that AMPK or Lkb1 deficiency did not affect energy stress-induced BNIP3 expression (Supplementary Figure 10) , which is also consistent with our data that FoxOs and LKB1-AMPK play differential roles in the regulation of apoptosis in response to energy stress (Figure 2) . Together, our data strongly suggest that FoxOs regulate BNIP3 expression and apoptosis under energy stress likely via AMPK-LKB1-independent mechanisms, although we do not rule out the possibility that It has also been shown recently that p38b inhibits mTORC1 in response to energy depletion via inactivation of Rheb in an AMPK-TSC-independent manner, although the exact role of p38b in energy stress-induced apoptosis remains elusive. 16 We confirmed that p38b KO cells were more resistant to energy stress-induced mTORC1 inactivation (Figure 7a ). Importantly, we found that p38b deletion rendered cells more resistant to energy stress-induced apoptosis (Figures 7b-d) , and energy stressinduced BNIP3 expression was significantly attenuated in p38b KO MEFs (Figure 7e ). In addition, re-expression of BNIP3 in Figure 11) . Thus, p38b and FoxOs function very similarly in the regulation of BNIP3 expression, mTORC1 inactivation and apoptosis induction under energy stress, suggesting that p38b and FoxOs may function in the same energy stress response pathway. A recent study showed that p38 interacts with FoxO3 and phosphorylates FoxO3 at Ser 7 under doxorubicin treatment. 36 Consistent with the recent report, we observed that energy stress induced p38b phosphorylation (data not shown). Importantly, we found that energy stress also increased FoxO3 phosphorylation at Ser 7, and energy stress-induced FoxO3 phosphorylation was abolished in p38b KO MEFs (Figure 7f ). Taken together, our data suggest a model that, in response to energy stress, p38b phosphorylates FoxO3 to upregulate BNIP3 expression, resulting in mTORC1 inhibition and apoptosis induction.
Low FoxO or BNIP3 expression correlates with poor clinical outcomes in renal cancer patients Out data that FoxO-BNIP3 functions to suppress mTORC1 and promote apoptosis under energy stress, together with our previous finding that FoxOs inhibit renal cancer development in mouse models, 25 suggest that FoxO and BNIP3 expression 37, 38 Kaplan-Meier analysis on patient survival showed that patients with BNIP3-low tumors had significantly shorter overall survival than those with BNIP3-high tumors (P ¼ 6.7 Â 10 -6 ; Figure 8a ). Likewise, patients with FoxO1/3-low tumors also had shorter survival than those with FoxO1/3-high tumors (Figure 8b) . Consistent with our data that FoxO1/3 double knockdown had more potent effect on mTORC1 activity and cell survival compared with FoxO1 or FoxO3 single knockdown in renal cancer cells (Figures 1f and 2h) , we found that combined FoxO1/3 expression (P ¼ 5.6 Â 10 -5 ; Figure 8b ) had more power to stratify the survival of ccRCC patients compared with either FoxO1 (P ¼ 1.6 Â 10 -3 ; Figure 8c ) or FoxO3 alone (P ¼ 1.4 Â 10 -3 ; Figure 8d ). In addition, FoxO4 expression showed similar result (P ¼ 1.6 Â 10 -3 ; Figure 8e ). Together, consistent with our in vitro findings, our data suggest that renal cancer patients with low expression of BNIP3 or FoxOs had poor clinical outcomes and suggest the potential use of BNIP3 or FoxO expression in prognostic stratification of ccRCC patients.
DISCUSSION
The function of AMPK in energy stress response has been extensively studied.
1,2 However, the roles and mechanisms of AMPK-independent pathways involved in energy stress response still remain largely unknown. In this study, we identify the p38b-FoxO-BNIP3 signaling axis as a novel pathway that functions independently of the LKB1-AMPK-TSC signaling in energy stress response (Figure 9a) . Importantly, these two signaling pathways play differential roles in cellular energy response to control cell survival: the LKB1-AMPK-TSC signaling axis serves to inhibit mTORC1 and promote cell survival during energy stress. Accordingly, deletion of AMPK, Lkb1, Tsc1 or Tsc2 or reconstitution of cells with a Raptor mutant that is nonphosphorylatable by AMPK leads to increased mTORC1 signaling/cell growth and increased apoptosis under energy stress (Figure 9b ). In contrast, p38b-FoxO-BNIP3 signaling functions to FoxO-BNIP3 in the regulation of energy stress response A Lin et al inhibit mTORC1 and promote apoptosis under energy stress. Cells with deficiency of p38b, FoxO or BNIP3 exhibit enhanced mTORC1 activity and decreased apoptosis under energy stress (Figure 9c) . We reason that cells may have adapted these two different mechanisms to couple cell survival with energy status under different situations, such that AMPK activation is mainly initiated to promote cell survival during short periods of energy stress, whereas p38b activation and FoxO-mediated BNIP3 induction are initiated to promote cell death when there is long-term energy stress. In line with this, BNIP3 transcription induction takes longer time than AMPK-mediated phosphorylation events, and it has been shown that p38b activation occurs later than AMPK phosphorylation of TSC2 and Raptor in response to energy stress. 16 The exact role of BNIP3 in cell death induction is somewhat controversial: although some studies showed that overexpression of BNIP3 is sufficient to induce cell death, other studies revealed negative results. 31 It is likely that the function of BNIP3 in cell death regulation is context dependent. In the cell lines we examined in this study, we found that BNIP3 overexpression did not induce obvious cell death under normal culture condition but could significantly induce cell death under glucose starvation condition. It is likely that BNIP3 exerts its cell killing effect only when other pro-apoptotic Bcl2 family proteins are also induced under glucose starvation condition. In line with this, it has been shown that Bim is also involved in the regulation of glucose starvation-induced cell death. 39 Our study may also provide important insights into human diseases related to energy stress, such as cancer. Tumor growth requires high-energy and high-nutrient supplies. As a result, cancer cells usually undergo various types of metabolic stress, including energy stress. Overcoming metabolic stress is a critical step in cancer development. 40 However, how cancer cells engage strategies of metabolic adaptation to survive and grow under metabolic stress is not well understood. As our data showed that inactivation of p38b, FoxOs or BNIP3 leads to increase in both mTORC1 signaling and cell survival, loss of this signaling axis may be one powerful strategy cancer cells adapt to energy stress during tumor development. In line with this, our study showed that renal cancer patients with low expression of BNIP3 or FoxOs had poor clinical outcomes. In addition, as AICAR is being tested as an anticancer agent, our data provide further speculation that FoxO or BNIP3 expression levels may be used to stratify cancer patients for AICAR treatment: tumors with high FoxO (or BNIP3) expression may be more sensitive to AICAR treatment than those with low FoxO (or BNIP3) expression. The exact roles of this signaling axis in the development and treatment of renal cancer or other cancers await further investigation.
A previous study suggested that FoxO3 inactivates mTORC1 via upregulation of TSC1 expression. 41 We found that FoxO deficiency did not affect TSC1 expression under energy stress (Supplementary Figure 12A) . In addition, deletion of FoxOs in Tsc1-deficient cells rendered Tsc1-deficient cells more resistant to energy stress-induced mTORC1 inactivation (Figure 3c ), strongly suggesting that FoxOs exert a TSC1-independent mechanism to regulate mTORC1 under energy stress. Another study reported that FoxOs inhibit mTORC1 via Rictor expression upregulation and mTORC2 activation at the expense of mTORC1. 42 We found that FoxO deletion did not affect Rictor expression under energy stress (Supplementary Figure 12) . Energy stress significantly increased AKT phosphorylation at both Ser 473 and Thr 308. However, there was no obvious difference of AKT phosphorylation between FoxO WT and KO cells under energy stress (Supplementary Figure 12) . We want to emphasize that our data are not incompatible with these previous findings, as our study simply suggests that FoxO regulation of mTORC1 function under energy stress is independent of TSC1 or Rictor. Given the context-specific function of FoxOs, 26 it is likely that FoxO regulation of mTORC1 involves different downstream targets under different conditions.
The previous study showed that AMPK or TSC2 deficiency does not affect energy stress-induced p38b activation, nor does p38b deficiency affect energy stress-induced AMPK, TSC2 and Raptor phosphorylation, 16 suggesting that p38b functions in parallel to AMPK-TSC signaling to mediate energy stress response. Our data revealed that both p38b and FoxOs regulate energy stress-induced BNIP3 expression, and p38b promotes energy stress-induced FoxO3 phosphorylation, suggesting that p38b and FoxO-BNIP3 may function in the same pathway to mediate energy stress response. It was reported that p38b regulates energy depletion suppression of mTORC1 at least in part via p38-regulated/activated protein kinase (PRAK). 16 Interestingly, both PRAK and BNIP3 control mTORC1 through inactivation of Rheb. 16, 33 These data together suggest that, in response to energy stress, p38b has two inhibitory effects on mTORC1: (1) p38b phosphorylation of PRAK and (2) p38b phosphorylation of FoxO and upregulation of BNIP3 expression. Both axes converge on Rheb. This is similar to the model that AMPK inactivation of mTORC1 involves AMPK phosphorylation of both TSC2 and Raptor.
MATERIALS AND METHODS

Generation and analysis of mice
The FoxO1/3/4L/L, Rosa26-CreERT2 mice were generated as described in our previous study. 25 Littermates of FoxO1/3/4L/L or FoxO1/3/4L/L, Rosa26-CreERT2 mice at 4-5 weeks of age were treated by intraperitoneal injection Figure 9 . The working model of FoxO in energy stress response. See the Discussion section for detailed description.
FoxO-BNIP3 in the regulation of energy stress response A Lin et al of tamoxifen 43, 44 to generate FoxO WT and KO mice. FoxO WT and KO mice were fed ad libitum or fasted for 24 h, and whole cell lysates from various organs were subjected to western blotting analysis. All animal manipulations were performed with the approval of MD Anderson Cancer Center's Institutional Animal Care and Use Committee (IACUC).
Cell culture studies
Human kidney cancer cell lines and human embryonic kidney cell line HEK293T used in this study were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). Lentiviruses or retroviruses were produced in HEK293T cells with packing mix (ViraPower Lentiviral Expression System, Invitrogen, Grand Island, NY, USA) and used to infect target cells as per the manufacturer's instruction. E14.5 embryos were harvested, and MEFs were isolated by standard methods. Primary FoxO1/3/ 4L/L, Rosa26-CreERT2 MEFs were treated with 200 nM 4OHT or vehicle for 4 days and then shifted to a normal medium (Dulbecco's modified Eagle's medium (DMEM) þ 10% fetal bovine serum (FBS)) after 4OHT treatment, resulting in FoxO WT and KO MEFs. The same strategy was used to generate Tsc1 or Lkb1 WT and KO MEFs used in this study. AMPK WT and KO MEFs were described by Laderoute et al., 45 and p38b WT and KO MEFs were described by Zheng et al. 16 The cells described in this study were routinely maintained in normal DMEM (containing 4.5 g/l glucose) þ 10% FBS. For glucose starvation experiments, 12-24 h after cell seeding, cells were shifted to glucosecontaining (4.5 g/l glucose) or glucose-free DMEM þ 10% dialyzed FBS. The cells were replenished with a fresh medium every 12 h and again 2 h before final analysis. To measure apoptosis, the cells were stained by the Annexin V kit as per the manufacturer's instruction (BD Bioscience, Franklin Lakes, NJ, USA) and then subjected to fluorescence-activated cell sorting analysis. In our experiments, propidium iodide-negative and Annexin V-positive populations were gated for analysis. To determine cell size and DNA content, fluorescence-activated cell sorting analysis with Cell Quest software was performed as previously described. 46 Reagents Lentiviral small hairpin RNA (shRNA) vectors targeting human FoxO1 and FoxO3 were described in our previous publication. 25 Lentiviral shRNA vectors targeting mouse BNIP3 were obtained from Open Biosystems (Lafayette, CO, USA). AICAR was purchased from Toronto Research Chemicals (TRI) (Toronto, ON, Canada). 2-Deoxy-glucose and 4OHT were purchased from Sigma (Garner, NC, USA). Rapamycin was purchased from Calbiochem (Billerica, MA, USA). The constructs used in this study are described in Supplementary Information.
Quantitative real-time PCR analysis
Total RNA was extracted from cells using RNeasy (Qiagen, Valencia, CA, USA), and first-strand cDNA was prepared with the High Capacity cDNA Reverse Transcription kit (Applied Biosystems, South San Francisco, CA, USA, ABI). Real-time PCR was performed using the QuantiTect SYBR Green PCR kit (Qiagen) or TaqMan Universal PCR Master Mix (ABI) and was run on Stratagene MX3000P. Primer sequences are provided in Supplementary Information.
Immunoprecipitation and western blot analysis
Tissues were lysed with radioimmunoprecipitation assay buffer (20 mM Tris (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mM EDTA, 0.1% sodium dodecyl sulfate) containing complete mini protease inhibitors (Roche, Branchburg, NJ, USA) and phosphatase inhibitor cocktail (Calbiochem). Cultured cells were lysed with NP-40 buffer (150 mM sodium chloride, 1.0% NP-40, 50 mM Tris, pH 8.0) containing complete mini protease inhibitors (Roche) and phosphatase inhibitor cocktail (Calbiochem). Western blots were obtained utilizing 20-40 mg of lysate protein.
Immunoprecipitation to detect protein-protein interaction was performed as previously described. 46 Briefly, cells were lysed in NETN buffer (20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40) containing protease inhibitors. Cell lysates were precleared with protein-A/G beads and incubated with the antibodies for 2 h and protein-A/G beads for additional 2 h at 4 1C. The beads were washed with NETN buffer and proteins were eluted for analysis.
The following antibodies were used in this study: vinculin (Sigma), S6K, LKB1, TSC2 (Santa Cruz Biotechnology, Dallas, TX, USA), LC3 (Novus Biologicals, Littleton, CO, USA), BNIP3 (Abcam, Cambridge, MA, USA), TSC1, FoxO1 (C29H4), FoxO3 (75D8), S6, Ser 240/244 phospho-S6, Thr 389 phospho-S6K, AMPK, Thr 172 phospho-AMPK, acetyl-CoA carboxylase, Ser 79 phospho-acetyl-CoA carboxylase, Raptor, Ser 792 phospho-Raptor, Ser 1387 phospho-TSC2, Rheb, AKT, Ser 473 phospho-AKT, Thr 308 phospho-AKT, p44/42 MAPK, poly(ADP-ribose) polymerase, cleaved caspase-3 and p38b (all from Cell Signaling Technology, Danvers, MA, USA). Ser 7 phospho-FoxO3 antibody was described in the previous publication. 36 
ChIP analysis
ChIP experiment was performed using the EZ-ChIP kit (Chemicon, Temecula, CA, USA) as per the manufacturer's instruction. The primer sequences used in ChIP experiment are described in Supplementary Information.
Luciferase reporter promoter assay HEK293T cells were transfected with FoxO expression vectors and luciferase reporter construct. Two days later, whole cell lysates were extracted, and luciferase activity was determined using the Dual-Luciferase Reporter Assay kit (Promega, Madison, WI, USA) and measured with an illuminometer instrument. Renilla was used as the internal control to determine luciferase activity. Three independent experiments were performed in each assay.
Expression profiling and computational analysis mRNA expression profiling was performed at the MD Anderson Cancer Center Microarray Core facility using the Mouse Genome 430 2.0 Array (Affymetrix, Santa Clara, CA, USA). Raw data were normalized by the 'rma' function from the R package 'affy' (downloaded from http://www.bioconductor.org). To identify genes differentially regulated by glucose deprivation, we performed SAM analysis (http://www.stat.stanford.edu/Btibs/ SAM/) on gene expression changes under glucose deprivation between FoxO WT and KO MEFs. This identified a list of 10 upregulated genes and 72 downregulated genes under condition of delta 0.44 and 15% false discovery rate (FDR). A representative heatmap was generated using expression data from top 15 genes with o5% FDR and 41.5-fold difference by the Cluster and TreeView software (Michael Eisen, http:// rana.lbl.gov/EisenSoftware.htm).
Kaplan-Meier survival analysis of ccRCC patients Level 3 RNA-seq data and clinical data for ccRCCs were downloaded from TCGA data portal (https://tcga-data.nci.nih.gov/tcga/dataAccessMatrix. htm). For a particular gene, patients were separated into two groups with high or low expression using kmeans function (k ¼ 2) of the R software. Kaplan-Meier analyses were performed using the 'survival' package of the R software. For analysis involving more than one FoxO genes, expression levels of each FoxO gene were combined (summed up) and then treated as a single gene.
